After establishing the crucial role of miR199a-5p in cardiac protection following cardiac injury, our next inquiry was whether P-MSN/miR199a-5p complexes could be employed as a potential therapeutic approach for the treatment of MI. This evidence concerns the gene MSN and myocardial infarction.